UBS Group Trims Axsome Therapeutics (NASDAQ:AXSM) Target Price to $105.00
Axsome Therapeutics (NASDAQ:AXSM – Free Report) had its price objective lowered by UBS Group from $107.00 to $105.00 in a research report released on Tuesday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. Other analysts have also issued reports about the company. Needham & Company LLC reaffirmed a buy rating […]
More Stories
Head to Head Comparison: SVB Financial Group (OTCMKTS:SIVPQ) and Consumers Bancorp (OTCMKTS:CBKM)
Consumers Bancorp (OTCMKTS:CBKM – Get Free Report) and SVB Financial Group (OTCMKTS:SIVPQ – Get Free Report) are both financial services...
KBR (NYSE:KBR) Cut to “Buy” at StockNews.com
StockNews.com lowered shares of KBR (NYSE:KBR – Free Report) from a strong-buy rating to a buy rating in a report...
StockNews.com Initiates Coverage on Avalon (NYSE:AWX)
StockNews.com initiated coverage on shares of Avalon (NYSE:AWX – Get Free Report) in a research note issued to investors on...
Intuit (NASDAQ:INTU) Cut to Hold at StockNews.com
StockNews.com cut shares of Intuit (NASDAQ:INTU – Free Report) from a buy rating to a hold rating in a report...
Prestige Consumer Healthcare (NYSE:PBH) versus MediciNova (NASDAQ:MNOV) Critical Comparison
Prestige Consumer Healthcare (NYSE:PBH – Get Free Report) and MediciNova (NASDAQ:MNOV – Get Free Report) are both medical companies, but...
Darden Restaurants (NYSE:DRI) Price Target Raised to $165.00
Darden Restaurants (NYSE:DRI – Free Report) had its price target lifted by Wells Fargo & Company from $160.00 to $165.00...